Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 05/14/2013

Company Name Symbol %Change
INTEROIL COR IOC
9.57%
INFORMATION III
9.47%
A M R CP AAMRQ
6.83%
SCIENTIFIC L SCIL
5.26%
PACER INTL I PACR
5.23%
Goldman Sachs to invest $20 million in BPL Medical Technologies

Print Share

May 13, 2013 (Datamonitor Financial Deals Tracker via COMTEX) -- Goldman Sachs Group, Inc., a US-based an investment banking, securities and investment management firm, has made an equity commitment INR1,100 ($20 million) to BPL Medical Technologies, an India-based medical device manufacturer.

Deal Value (US$ Million) 20
Deal Type                Private Equity
Sub-Category             DIRECT INVESTMENT
Deal Status              Announced: 2013-05-13

Deal Participants

Target (Company) BPL Medical Technologies

Deal Rationale

BPL Medical will use the funds to expand its business.

(c) 2001-2007 Datamonitor. All rights reserved. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon.

**********************************************************************

As of Thursday, 05-09-2013 23:59, the latest Comtex SmarTrendA? Alert,
an automated pattern recognition system, indicated a DOWNTREND on
04-05-2012 for GS @ $119.11.

For more information on SmarTrend, contact your market data
provider or go to www.mysmartrend.com

SmarTrend is a registered trademark of Comtex News Network, Inc.
Copyright A? 2004-2013 Comtex News Network, Inc. All rights reserved.

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.